Cost Effectiveness and Cost Utility of Acetylcysteine versus Dimethyl Sulfoxide for Reflex Sympathetic Dystrophy
Year of publication: |
2003
|
---|---|
Authors: | van Dieten, Hiske E.M. ; Perez, Roberto S.G.M. ; van Tulder, Maurits W. ; de Lange, Jaap J. ; Zuurmond, Wouter W.A. ; Ader, Herman J. ; Vondeling, Hindrik ; Boers, Maarten |
Published in: |
PharmacoEconomics. - Springer Healthcare | Adis, ISSN 1170-7690. - Vol. 21.2003, 2, p. 139-148
|
Publisher: |
Springer Healthcare | Adis |
Subject: | Acetylcysteine | Cost analysis | Cost utility | Dimethyl sulfoxide | Pharmacoeconomics | Reflex sympathetic dystrophy |
Extent: | application/pdf text/html |
---|---|
Type of publication: | Article |
Classification: | C - Mathematical and Quantitative Methods ; D - Microeconomics ; I - Health, Education, and Welfare ; Z - Other Special Topics ; I1 - Health ; I19 - Health. Other ; I18 - Government Policy; Regulation; Public Health ; I11 - Analysis of Health Care Markets |
Source: |
-
Mavissakalian, Matig R., (2000)
-
Cost Effectiveness of Treatments for Amyotrophic Lateral Sclerosis: A Review of the Literature
Ginsberg, Gary, (2002)
-
Pharmacoeconomics of Hypertension Management: The Place of Combination Therapy
Ambrosioni, Ettore, (2001)
- More ...
-
Korthals-de Bos, Ingeborg B.C., (2004)
-
Palliative care is not yet a well-defined product within the Dutch healthcare insurance system
Jansen, Wim J.J., (2009)
-
Recent Developments for Optimal End-Points in Rheumatoid Arthritis Clinical Studies
Molenaar, Esmeralda T.H., (2000)
- More ...